autologous mesoangioblasts

BIOLOGICAL2 trials

Sponsors

Academisch Ziekenhuis Maastricht, Maastricht University

Conditions

Mitochondrial Myopathiesm.3243A>G mutation causing mitochondrial myopathy

Phase 1

MABs Therapy m.3243A>G Mutation Carriers

CompletedNCT05063721

Maastricht UniversityMitochondrial Myopathies

Start: 2020-03-01End: 2022-12-01Updated: 2024-01-17

Assess efficacy of intra-arterial autologous myogenic stam cell therapy for m.3243A>G mutation carriers

Not yet recruitingCTIS2024-515129-27-00

Academisch Ziekenhuis Maastrichtm.3243A>G mutation causing mitochondrial myopathy

Target: 20Updated: 2025-04-08